Finally, in vitro and in vivo, we show that MET inhibition radiosensitizes tumors, by improving the overall control of tumor growth, and, most importantly, by converting the danger of GBM stem‐like cell‐positive selection into the benefit of their depletion. Here, MET is linked to glioblastoma.